Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03ZBS
|
||||
Former ID |
DNC014026
|
||||
Drug Name |
4-cyanophenyl ethyl dodecylphosphonate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529659] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H34NO3P
|
||||
Canonical SMILES |
CCCCCCCCCCCCP(=O)(OCC)OC1=CC=C(C=C1)C#N
|
||||
InChI |
1S/C21H34NO3P/c1-3-5-6-7-8-9-10-11-12-13-18-26(23,24-4-2)25-21-16-14-20(19-22)15-17-21/h14-17H,3-13,18H2,1-2H3
|
||||
InChIKey |
FHIBETIKXBGJPS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [529659] | |
Fatty-acid amide hydrolase | Target Info | Inhibitor | [529659] | ||
BioCyc Pathway | Anandamide degradation | ||||
PANTHER Pathway | Endogenous cannabinoid signalingP05728:Anandamide degradation | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.